Research and Development

Showing 15 posts of 9612 posts found.

epilepsy-623346_960_720

Cannabidiol drug found to aid in devastating childhood epilepsy condition

May 25, 2017 Research and Development GW Pharmaceuticals, cannabidoil, epilepsy

A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
hiv

Inovio posts “exceptional” results for HIV vaccine

May 25, 2017 Research and Development AIDS, HIV, HIV vaccine, Vaccine

Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
keytruda3-web

MSD receives first FDA approval based on specific genetic feature

May 24, 2017 Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
syringe-1973129_960_720

Antibiotics found to fail in quarter of pneumonia patients

May 24, 2017 Research and Development Antibiotics, antibiotic resistance, pneumonia

A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …
merckincweb1

MSD under CMA investigation over unfair Remicade pricing

May 24, 2017 Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade

MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
scott_gottlieb

Opioid crisis “highest initial priority” for new FDA Commissioner

May 24, 2017 Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis

Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …

European approval for novel Eisai epilepsy monotherapy

May 23, 2017 Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy

Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
2919193_kenneth

Nativis Incorporated appoints new CSO

May 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
astrazeneca_plaque

Strong showing for AZ asthma drug, but diabetes treatment flops

May 23, 2017 Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes

AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …
janeg

J&J lines up its Global Head for Actelion

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Janssen, Johnson & Johnson

The deal is not yet complete but the last steps are assumed to be a formality – at least Johnson …

Behind the NHS recruitment crisis

May 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, laid a stark warning at the door of the …

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …
amgen_hq

Amgen hit by major safety blow on osteoporosis drug

May 22, 2017 Research and Development, Sales and Marketing Amgen, Romosozumab, UCB SA

Amgen and UCB SA have been delivered a crushing blow in its attempt to have a drug for osteoporosis approved …
melanoma

No causal link between Viagra use and melanoma, study finds

May 19, 2017 Medical Communications, Research and Development melanoma, viagra

Research from the NYU Langone Medical Center and its Perlmutter Cancer Center, based in New York City, has indicated that …
The Gateway to Local Adoption Series

Latest content